logo
Plus   Neg
Share
Email

Teva Pharmaceutical CFO Michael McClellan To Step Down - Quick Facts

Israeli generic medicines producer Teva Pharmaceutical Industries (TEVA) announced Wednesday that Executive Vice President and Chief Financial Officer Michael McClellan has decided to step down from his role as CFO due to personal reasons requiring him to be located near his family.

Teva has initiated a search to identify its next CFO. McClellan is expected to remain in his role through the announcement of third quarter results to assist with a smooth transition.

McClellan was appointed Teva's CFO in November 2017 after serving as Senior Vice President and Interim Group CFO from July 2017. From 2015 to November 2017, McClellan served as senior vice president and CFO, Global Specialty Medicines.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration on Tuesday unveiled a new international collaboration for simultaneous review and approval of cancer drugs along with the agency's Australian and Canadian counterparts. The simultaneous approval of cancer therapies by the three regulators is intended to accelerate the process of making these new treatments available to patients around the world. Humanscale Corp. recalled about 24,900 units of QuickStand Lite workstations for concerns of injury hazard. These include about 2,200 units sold in Canada. The recalled workstation's arm can break and cause the workstation to fall, posing a risk of injury. The company has already received 52 reports of the arm breaking, including 12 reports of minor injuries. Facebook has revealed more details on the structure of an independent "oversight board" that will make final decisions about what posts stay up or come down, even if the company disagrees. The new "Oversight Board" will govern appeals from both Facebook and its users.
Follow RTT